| 12:00 - 13:00 | Satellite Symposium: TID: Stewardship in transplant infectious diseases |
2 |
CMV Stewardship Camille N. Kotton, United States |
| 08:00 - 09:15 | Abstract Session: Complications in transplantation |
| 202.4 (302.3 in the journal) |
Differences in High and Low Dose Belatacept Conversion Effects in Kidney Transplant Patients Hay Me Me, United States |
| 10:40 - 12:10 | Abstract Session: Bacterial and viral infections |
| 222.1 |
Nocardiosis in living related donor kidney transplant recipients: A study from a low income country Sana Jamil, Pakistan |
| 222.5 |
Predictors of post-transplant CMV disease in kidney transplant recipients – A Collaborative Transplant Study (CTS) report Elif Dogan Dar, Germany |
| 222.6 |
Immune markers are predictive of CMV infection in seropositive lung transplant recipients Bradley J Gardiner, Australia |
| 222.8 |
Effect of recurrent CMV viremia on graft and patient survival in renal transplantation Paul A Keown, Canada |
222.9 |
Incidence of Antibiotic-Resistant Urinary Tract Infection after Kidney Transplant and Associated Antibiotic Use Sapna A Mehta, United States |
| 10:40 - 12:10 | Abstract Session: Transplant immunosuppression 1 |
| 225.9 |
Delayed Immune Tolerance for Cardiac Allografts in Nonhuman Primates by Targeting CD154, CD2, and CD28 Costimulation Pathways Sho Takemoto, United States |
| 13:40 - 15:10 | Abstract Session: General infectious diseases 1 |
| 242.3 |
Deep cutaneous fungal infections in kidney transplant recipients Abdullah Ansari, India |
| 13:40 - 15:10 | Abstract Session: Intestinal transplant |
| 245.4 |
Living donor intestinal transplantation: Two decades of experience in China Guosheng Wu, People's Republic of China |
| 245.7 |
Outcomes of intestinal transplant in a single large adult centre Bala Mahesh Polamreddy, United Kingdom |
| 13:40 - 15:10 | Abstract Session: Predictive model in transplantation |
| 249.2 |
Outcomes of liver transplantation in patients 60 years and older: a multivariate analysis using penalized Cox regression Eliz Peyraud, France |
| 16:50 - 18:30 | Abstract Session: Lung Transplantation |
| 16:50 - 18:30 | Abstract Session: Immunoregulation, tolerance and other topics |
| 265.2 |
Assessing the Potency of Autologous MSCs by correlating Serum IDO levels and regulatory T cell in Living-Donor Kidney Transplant Recipients Omaima M Sabek, United States |
| 08:00 - 09:15 | Workshop: Enhancing outcomes: BK and CMV guidelines after solid organ transplantation |
|
304.1 |
Navigating BK guidelines: A roadmap for solid organ transplantation Camille N. Kotton, United States |
304.2 |
Empowering transplant teams: CMV guidelines for optimal patient care Atul Humar, Canada |
|
Challenging cases and Q&A Discussion Period, Turkey |
| 13:40 - 15:10 | Abstract Session: General Infectious Diseases 2 |
| 342.2 |
ATG dose is associated with CMV viremia but not BK viremia in living donor kidney transplants Isik H Ozgu, Turkey |
| 342.3 |
Comparison of risk factors and outcome between high and low Cytomegalovirus viremia in living donor R+D+ renal transplant recipients from Pakistan Ejaz Ahmed, Pakistan |
| 342.9 |
Etiology of Diarrhea in Renal Allograft Recipients using FilmArray GI panel test and Graft Outcome at a tertiary care centre from India.
Presenter will be Dr Yogita sharma Yogita Sharma, India |
| 342.10 |
Evaluation of CMV Hyperimmunoglobulin Use in a large European non-interventional, multicenter study after heart and lung transplantation Markus J. Barten, Germany |
| 13:40 - 15:10 | Abstract Session: Liver rejections, markers and complications |
| 343.8 |
The short- and long-term outcomes of steroid-free regimen in liver transplantation Kazuki Sasaki, Japan |
| 16:50 - 18:30 | Abstract Session: Kidney Outcomes 2 |
| 360.1 |
Long-term kidney transplant recipients exhibit a dominance of T-lymphocyte subpopulations with an immunosenescent phenotype Asimina Fylaktou, Greece |
| 16:50 - 18:30 | Abstract Session: Liver pediatric and miscellaneous |
| 364.3 |
Risk factors and outcomes of neutropenia following pediatric liver transplantation F. Burcu Belen Apak, Turkey |
| 13:40 - 15:10 | Abstract Session: Kidney Outcomes and Complications 2 |
| 440.2 |
Clinical study of the importance of IgG level in kidney transplant recipient Yasushi Mochizuki, Japan |
| 13:40 - 15:10 | Abstract Session: Kidney Post-transplant Management Issues |
| 441.8 |
Impact of recipient frailty on infection risk after kidney transplantation Inji Alshaer, United Kingdom |